RND1 and glioblastoma: Moreover, based on TCGA, we measured RND1 expression in subtypes of GBM, including classical (CL), mesenchymal (ME), and proneural (PR) GBM, where ME GBM, which shows the highest malignancy [18], had lower RND1 expression than CL and PR GBM (Fig. 1C).